Trial Profile

Phase 1 clinical trial of Dotinurad for the treatment of gout

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 01 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dotinurad (Primary)
Indications Gout
Focus Adverse reactions

Most Recent Events

15 Nov 2023 Results (n=15) assessing Pharmacokinetics and Pharmacodynamic Profiles of Dotinurad in Healthy subjects presented at the ACR Convergence 2023
29 Jun 2023 Topline results presented in the Urica Therapeutics Media Release.
15 May 2023 According to a Fortress Biotech media release, topline data is expected in the second quarter of 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com